Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 288.35
-16.65 (-5.46%)
At close: Jan 21, 2026
Trident Lifeline Market Cap
Trident Lifeline has a market cap or net worth of 3.44 billion as of January 23, 2026. Its market cap has decreased by -0.26% in one year.
Market Cap
3.44B
Enterprise Value
4.06B
Revenue
1.27B
Ranking
n/a
PE Ratio
20.93
Stock Price
288.35
Market Cap Chart
Since October 10, 2022, Trident Lifeline's market cap has increased from 1.24B to 3.44B, an increase of 176.68%. That is a compound annual growth rate of 36.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.56B | -3.88% |
| Dec 31, 2025 | 3.71B | 15.15% |
| Dec 30, 2024 | 3.22B | 48.94% |
| Dec 29, 2023 | 2.16B | 51.61% |
| Dec 30, 2022 | 1.43B | 14.66% |
| Oct 10, 2022 | 1.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 5.13B |
| Jenburkt Pharmaceuticals | 4.70B |
| Sudarshan Pharma Industries | 4.67B |
| Medicamen Biotech | 4.50B |
| Everest Organics | 4.03B |
| Albert David | 3.91B |
| Medico Remedies | 3.71B |
| Amanta Healthcare | 3.45B |